# OnCo record nct06904235 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct06904235/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct06904235", "NCT06904235" ;
  schema:name "Study With IV NEPA (Fosnetupitant/Palonosetron) for the Prevention of Chemotherapy-induced Nausea and Vomiting in Paediatric Cancer Patients Undergoing Highly Emetogenic Chemotherapy (HEC)"@en ;
  schema:description "A phase 2 trial of Palonosetron, Ondansetron and Aprepitant (and fosaprepitant) in childhood cancers, run by Helsinn Healthcare SA, now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct06904235/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT06904235> ;
  onco:status "recruiting" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "2" ;
  schema:startDate "2025-07-07" ;
  onco:cancers <https://onco.cc/cancers/childhood-cancers/> ;
  onco:technologies <https://onco.cc/technologies/antiemetic-therapy/> ;
  onco:drugs <https://onco.cc/drugs/palonosetron/>, <https://onco.cc/drugs/ondansetron/>, <https://onco.cc/drugs/aprepitant/> ;
  onco:companies <https://onco.cc/companies/helsinn/> .